Nachrichten | Page 6 | bioMérieux Switzerland

bioMérieux receives FDA 510(k) clearance for its BacT/ALERT^® VIRTUO^™ fully automated blood culture system

07 April, 2017

bioMérieux – 2016 Financial Results

01 März, 2017

bioMérieux’s VIDAS^® B•R•A•H•M•S PCT^™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis

24 Februar, 2017

bioMérieux – Fourth-Quarter 2016 Business Review

19 Januar, 2017

bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury

19 Januar, 2017

bioMérieux launches EMAG^®, a new generation automated system for the extraction of DNA and RNA

10 November, 2016

Business Review for the nine months ended September 30, 2016

20 Oktober, 2016

bioMérieux – First-Half 2016 Results

31 August, 2016

bioMérieux – Second-Quarter 2016 Business Review

18 Juli, 2016

bioMérieux enlarges its pathogen identification capability on VITEK^® MS

06 Juli, 2016

With a database of more than 15,000 strains VITEK^® MS improves clinical decision-making for infectious diseases

Pioneering diagnostics